Log In
BCIQ
Print this Print this
 

Orexa (S1P-205)

  Manage Alerts
Collapse Summary General Information
Company S1 Biopharma Inc.
DescriptionUnavailable
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentIND
Standard IndicationSexual dysfunction
Indication DetailsTreat hypoactive sexual desire disorder (HSDD) in men; Treat hypoactive sexual desire disorder (HSDD) in menopausal women
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today